NK cells during dengue disease and their recognition of dengue virus-infected cells

Frontiers in Immunology

Volumn 5, Issue MAY, 2014, Pages

  Beltrán, Davis ^a,b,c   López Vergès, Sandra ^a  

^a GORGAS MEMORIAL INSTITUTE FOR HEALTH STUDIES   (Panama)

^b INSTITUTO DE INVESTIGACIONES CIENTÍFICAS Y SERVICIOS DE ALTA TECNOLOGÍA   (Panama)

^c ACHARYA NAGARJUNA UNIVERSITY   (India)

Author keywords

Dengue; Innate immune response; NK cell; NK ligand; NK receptor

Indexed keywords

CELL DIFFERENTIATION; CYTOKINE PRODUCTION; DENGUE; DISEASE SEVERITY; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; INNATE IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONHUMAN; SHORT SURVEY; VIRAL CLEARANCE; VIRUS REPLICATION;

EID: 84987818068     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00192     Document Type: Short Survey

References (62)

1. Halstead SB. Dengue. Lancet (2007) 370(9599):1644-52. doi:10.1016/S0140-6736(07)61687-0
2. Anon. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. Geneva: World Health Organization and the Special Programme for Research and Training in Tropical diseases (2009). p. 25-8.
3. OhAinle M, Balmaseda A, Macalalad AR, Tellez Y, Zody MC, Saborío S, et al. Dynamics of dengue disease severity determined by the interplay between viral genetics and serotype-specific immunity. Sci Transl Med (2011) 3(114):114ra128. doi:10.1126/scitranslmed.3003084
4. Whitehorn J, Simmons CP. The pathogenesis of dengue. Vaccine (2011) 29(42):7221-8. doi:10.1016/j.vaccine.2011.07.022
5. Yacoub S, Mongkolsapaya J, Screaton G. The pathogenesis of dengue. Curr Opin Infect Dis (2013) 26(3):284-9. doi:10.1097/QCO.0b013e32835fb938
6. Kurane I, Innis BL, Nimmannitya S, Nisalak A, Rothman AL, Livingston PG. et al. Human immune response to dengue virus. Southeast Asian J Trop Med Public Health (1990) 21(4):658-62.
7. Green AM, Beatty PR, Hadjilaou A, Harris E. Innate immunity to dengue virus infection and subversion of antiviral responses. J Mol Biol (2014) 426(6):1148-60. doi:10.1016/j.jmb.2013.11.023
8. Navarro-Sánchez E, Desprès P, Cedillo-Barrón L. Innate immune responses to dengue virus. Arch Med Res (2005) 36(5):425-35. doi:10.1038/jid.2012.76
9. Sun P, Kochel TJ. The battle between infection and host immune responses of dengue virus and its implication in dengue disease pathogenesis. ScientificWorldJournal (2013) 2013:843469. doi:10.1155/2013/843469
10. Durbin AP, Vargas MJ, Wanionek K, Hammond SN, Gordon A, Rocha C, et al. Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever. Virology (2008) 376(2):429-35. doi:10.1016/j.virol.2008.03.028
11. Duyen HT, Ngoc TV, Hado T, Hang VT, Kieu NT, Young PR, et al. Kinetics of plasma viremia and soluble nonstructural protein 1 concentrations in dengue: differential effects according to serotype and immune status. J Infect Dis (2011) 203(9):1292-300. doi:10.1093/infdis/jir014
12. Libraty DH, Young PR, Pickering D, Endy TP, Kalayanarooj S, Green S, et al. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J Infect Dis (2002) 186(8):1165-8. doi:10.1086/343813
13. Srikiatkhachorn A, Wichit S, Gibbons RV, Green S, Libraty DH, Endy TP, et al. Dengue viral RNA levels in peripheral blood mononuclear cells are associated with disease severity and preexisting dengue immune status. PLoS One (2012) 7(12):e51335. doi:10.1371/journal.pone.0051335
14. Tricou V, Minh NN, Farrar J, Tran HT, Simmons CP. Kinetics of viremia and NS1 antigenemia are shaped by immune status and virus serotype in adults with dengue. PLoS Negl Trop Dis (2011) 5(9):e1309. doi:10.1371/journal.pntd.0001309
15. Sun JC, Lanier LL. NK cell development, homeostasis and function: parallels with CD8+ T cells. Nat Rev Immunol (2011) 11(10):645-57. doi:10.1038/nri3044
16. Min-Oo G, Kamimura Y, Hendricks DW, Nabekura T, Lanier LL. Natural killer cells: walking three paths down memory lane. Trends Immunol (2013) 34(6):251-8. doi:10.1016/j.it.2013.02.005
17. Della Chiesa M, Sivori S, Castriconi R, Marcenaro E, Moretta A. Pathogen-induced private conversations between natural killer and dendritic cells. Trends Microbiol (2005) 13(3):128-36. doi:10.1016/j.tim.2005.01.006
18. Robertson MJ. Role of chemokines in the biology of natural killer cells. J Leukoc Biol (2002) 71(2):173-83.
19. Finton KA, Strong RK. Structural insights into activation of antiviral NK cell responses. Immunol Rev (2012) 250(1):239-57. doi:10.1111/j.1600-065X.2012.01168.x
20. Lanier LL. Evolutionary struggles between NK cells and viruses. Nat Rev Immunol (2008) 8(4):259-68. doi:10.1038/nri2276
21. López-Botet M, Angulo A, Gumá M. Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection. Tissue Antigens (2004) 63(3):195-203. doi:10.1111/j.1399-0039.2004.00210.x
22. 2D ligand expression on host immune responses. Immunol Rev (2010) 235(1):267-85. doi:10.1111/j.0105-2896.2010.00893.x
23. 2D and DNAM-1 ligand expression in normal, infected, and cancer cells. Front Immunol (2014) 4:508. doi:10.3389/fimmu.2013.00508
24. 2D and T-cell activation. Nature (2002) 419(6908):734-8. doi:10.1038/nature01112
25. 2D expression and cytotoxicity of NK cells. FASEB J (2013) 27(6):2440-50. doi:10.1096/fj.12-223057
26. -1 infection is associated with profound NK cell dysfunction. Virology (2010) 406(1):12-20. doi:10.1016/j.virol.2010.05.014
27. Green S, Pichyangkul S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Nisalak A, et al. Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever. J Infect Dis (1999) 180(5):1429-35. doi:10.1016/j.jmb.2013.11.023
28. Homchampa P, Sarasombath S, Suvatte V, Vongskul M. Natural killer cells in dengue hemorrhagic fever/dengue shock syndrome. Asian Pac J Allergy Immunol (1988) 6(2):95-102.
29. Wahid SF, Sanusi S, Zawawi MM, Ali RA. A comparison of the pattern of liver involvement in dengue hemorrhagic fever with classic dengue fever. Southeast Asian J Trop Med Public Health (2000) 31(2):259-63.
30. Chau TNB, Quyen NT, Thuy TT, Tuan NM, Hoang DM, Dung NT, et al. Dengue in Vietnamese infants-results of infection-enhancement assays correlate with age-related disease epidemiology, and cellular immune responses correlate with disease severity. J Infect Dis (2008) 198(4):516-24. doi:10.1086/590117
31. Azeredo EL, De Oliveira-Pinto LM, Zagne SM, Cerqueira DI, Nogueira RM, Kubelka CF. NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease. Clin Exp Immunol (2006) 143(2):345-56. doi:10.1111/j.1365-2249.2006.02996.x
32. Devignot S, Sapet C, Duong V, Bergon A, Rihet P, Ong S, et al. Genome-wide expression profiling deciphers host responses altered during dengue shock syndrome and reveals the role of innate immunity in severe dengue. PLoS One (2010) 5(7):e11671. doi:10.1371/journal.pone.0011671
33. Shresta S, Kyle JL, Robert Beatty P, Harris E. Early activation of natural killer and B cells in response to primary dengue virus infection in A/J mice. Virology (2004) 319(2):262-73. doi:10.1016/j.virol.2003.09.048
34. Shresta S, Sharar KL, Prigozhin DM, Snider HM, Beatty PR, Harris E. Critical roles for both STAT1-dependent and STAT1-independent pathways in the control of primary dengue virus infection in mice. J Immunol (2005) 175(6):3946-54. doi:10.4049/jimmunol.175.6.3946
35. St John AL, Rathore AP, Yap H, Ng ML, Metcalfe DD, Vasudevan SG, et al. Immune surveillance by mast cells during dengue infection promotes natural killer (NK) and NKT-cell recruitment and viral clearance. Proc Natl Acad Sci USA (2011) 108(22):9190-5. doi:10.1073/pnas.1105079108
36. Chen J-P, Lu HL, Lai SL, Campanella GS, Sung JM, Lu MY, et al. Dengue virus induces expression of CXC chemokine ligand 10/IFN-gamma-inducible protein 10, which competitively inhibits viral binding to cell surface heparan sulfate. J Immunol (2006) 177(5):3185-92. doi:10.4049/jimmunol.177.5.3185
37. Sung JM, Lee C-K, Wu-Hsieh BA. Intrahepatic infiltrating NK and CD8 T cells cause liver cell death in different phases of dengue virus infection. PLoS One (2012) 7(9):e46292. doi:10.1371/journal.pone.0046292
38. Renneson J, Guabiraba R, Maillet I, Marques RE, Ivanov S, Fontaine J, et al. A detrimental role for invariant natural killer T cells in the pathogenesis of experimental dengue virus infection. Am J Pathol (2011) 179(4):1872-83. doi:10.1016/j.ajpath.2011.06.023
39. Guabiraba R, Besnard AG, Marques RE, Maillet I, Fagundes CT, Conceição TM, et al. IL-22 modulates IL-17A production and controls inflammation and tissue damage in experimental dengue infection. Eur J Immunol (2013) 43(6):1529-44. doi:10.1002/eji.201243229
40. Suwannasaen D, Romphruk A, Leelayuwat C, Lertmemongkolchai G. Bystander T cells in human immune responses to dengue antigens. BMC Immunol (2010) 11:47. doi:10.1186/1471-2172-11-47
41. 18 combined action and mediates host resistance to dengue virus infection in a nitric oxide-dependent manner. PLoS Negl Trop Dis (2011) 5(12):e1449. doi:10.1371/journal.pntd.0001449
42. Kurane I, Hebblewaite D, Brandt WE, Ennis FA. Lysis of dengue virus-infected cells by natural cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity. J Virol (1984) 52(1):223-30.
43. Kurane I, Hebblewaite D, Ennis FA. Characterization with monoclonal antibodies of human lymphocytes active in natural killing and antibody-dependent cell-mediated cytotoxicity of dengue virus-infected cells. Immunology (1986) 58(3):429-36.
44. Laoprasopwattana K, Libraty DH, Endy TP, Nisalak A, Chunsuttiwat S, Ennis FA, et al. Antibody-dependent cellular cytotoxicity mediated by plasma obtained before secondary dengue virus infections: potential involvement in early control of viral replication. J Infect Dis (2007) 195(8):1108-16. doi:10.1086/512860
45. Lanier LL, Kipps TJ, Phillips JH. Functional properties of a unique subset of cytotoxic CD3+ T lymphocytes that express Fc receptors for IgG (CD16/Leu-11 antigen). J Exp Med (1985) 162(6):2089-106. doi:10.1084/jem.162.6.2089
46. Hershkovitz O, Zilka A, Bar-Ilan A, Abutbul S, Davidson A, Mazzon M, et al. Dengue virus replicon expressing the nonstructural proteins suffices to enhance membrane expression of HLA class I and inhibit lysis by human NK cells. J Virol (2008) 82(15):7666-76. doi:10.1128/JVI.02274-07
47. Lobigs M, Blanden RV, Müllbacher A. Flavivirus-induced up-regulation of MHC class I antigens; implications for the induction of CD8+ T-cell-mediated autoimmunity. Immunol Rev (1996) 152:5-19. doi:10.1111/j.1600-065X.1996.tb00908.x
48. Lobigs M, Müllbacher A, Regner M. MHC class I up-regulation by flaviviruses: immune interaction with unknown advantage to host or pathogen. Immunol Cell Biol (2003) 81(3):217-23. doi:10.1046/j.1440-1711.2003.01161.x
49. Momburg F, Müllbacher A, Lobigs M. Modulation of transporter associated with antigen processing (tap)-mediated peptide import into the endoplasmic reticulum by flavivirus infection. J Virol (2001) 75(12):5663-71. doi:10.1128/JVI.75.12.5663-5671.2001
50. Müllbacher A, Lobigs M. Up-regulation of MHC class I by flavivirus-induced peptide translocation into the endoplasmic reticulum. Immunity (1995) 3(2):207-14. doi:10.1016/1074-7613(95)90090-X
51. Ye J, Zhu B, Fu ZF, Chen H, Cao S. Immune evasion strategies of flaviviruses. Vaccine (2013) 31(3):461-71. doi:10.1016/j.vaccine.2012.11.015
52. Lobigs M, Müllbacher A, Lee E. Evidence that a mechanism for efficient flavivirus budding upregulates MHC class I. Immunol Cell Biol (2004) 82(2):184-8. doi:10.1046/j.0818-9641.2004.01218.x
53. Vargin VV, Semenov BF. Changes of natural killer cell activity in different mouse lines by acute and asymptomatic flavivirus infections. Acta Virol (1986) 30(4):303-8.
54. Bryceson YT, March ME, Ljunggren H-G, Long EO. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood (2006) 107(1):159-66. doi:10.1182/blood-2005-04-1351
55. NKp44 receptor mediates interaction of the envelope glycoproteins from the West Nile and dengue viruses with NK cells. J Immunol (2009) 183(4):2610-21. doi:10.4049/jimmunol.0802806
56. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J Exp Med (1998) 187(12):2065-72. doi:10.1084/jem.187.12.2065
57. Arnon TI, Markel G, Mandelboim O. Tumor and viral recognition by natural killer cells receptors. Semin Cancer Biol (2006) 16(5):348-58. doi:10.1016/j.semcancer.2006.07.005
58. Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol (2001) 19:197-223. doi:10.1146/annurev.immunol.19.1.197
59. García G, del Puerto F, Pérez AB, Sierra B, Aguirre E, Kikuchi M, et al. Association of MICA and MICB alleles with symptomatic dengue infection. Hum Immunol (2011) 72(10):904-7. doi:10.1016/j.humimm.2011.06.010
60. Khor CC, Chau TN, Pang J, Davila S, Long HT, Ong RT, et al. Genome-wide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1. Nat Genet (2011) 43(11):1139-41. doi:10.1038/ng.960
61. Whitehorn J, Chau TN, Nguyet NM, Kien DT, Quyen NT, Trung DT, et al. Genetic variants of MICB and PLCE1 and associations with non-severe dengue. PLoS One (2013) 8(3):e59067. doi:10.1371/journal.pone.0059067
62. Lang PA, Lang KS, Xu HC, Grusdat M, Parish IA, Recher M, et al. Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity. Proc Natl Acad Sci U S A (2012) 109(4):1210-5. doi:10.1073/pnas.1118834109